tirzepatide subcutaneous – SpringCare Clinic First Time Tirzepatide - Neo

The next generation of GLP-1 medications The GLP-1 landscape is evolving rapidly

It has no approved indication and no established legal pathway for prescription or pharmacy compounding in the United States

Instead, the body loses fat overall depending on genetics, calorie balance, and activity levels

Tirzepatide offers a non-surgical weight loss alternative, providing a gradual and sustainable approach without the risks and recovery time associated with bariatric surgery

(PubMed) Reid ME, Duffield-Lillico AJ, Slate E, et al

Dual Mechanism Advantage Dual Mechanism Advantage Tirzepatide activates both GIP and GLP-1 receptors : GLP-1 controls appetite and slows gastric emptying